Showing results (581-590 of 690) with videos related to

Sort By:
Pageof 69
Alzheimer Disease and Associated Disorders|January 1, 1997
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative StudyJ A Mackell, S H Ferris, R Mohs, et al.
The Journal of Nutrition, Health & Aging|October 27, 2006
Realistic expectations for treatment success in Alzheimer's diseaseD S Geldmacher, L Frolich, R S Doody, et al.
Plos One|November 11, 2014
Keratocytes derived from spheroid culture of corneal stromal cells resemble tissue resident keratocytesYong-Soo Byun, Sapna Tibrewal, Eunjae Kim, et al.
The European Journal of Surgery = Acta Chirurgica|November 22, 2001
Postoperative chemoendocrine therapy for women with node-positive stage II breast cancer with combined cyclophosphamide, tamoxifen, and 1-hexylcarbamoyl-5-fluorouracilT Tominaga, M Sano, T Nishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 10, 1999
[A case of advanced gastric cancer with abdominal para-aortic lymph node metastasis successfully treated with FLP therapy]T Tanabe, A Nashimoto, J Sasaki, et al.
Biochimica Et Biophysica Acta|November 24, 1999
The EAT/mcl-1 gene, an inhibitor of apoptosis, is up-regulated in the early stage of acute myocardial infarctionK Matsushita, A Umezawa, S Iwanaga, et al.
The Journal of Prevention of Alzheimer'S Disease|June 8, 2021
Mail and Telephone Outreach from Electronic Health Records for Research Participation on Cognitive Health and AgingK Pun, C W Zhu, M T Kinsella, et al.
Japanese Journal of Clinical Oncology|December 9, 1997
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology GroupS Takashima, T Saeki, I Adachi, et al.
Cancer Letters|August 4, 2001
Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazineA Hagiwara, K Miyashita, T Nakanishi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2009
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)N Katsumata, T Watanabe, H Minami, et al.
Pageof 69